Tarsus Pharmaceuticals Stock (NASDAQ: TARS) stock price, news, charts, stock research, profile.
Open | $34.62 |
Close | $34.51 |
Volume / Avg. | 1.21M / 787.23K |
Day Range | $33.73 - $34.93 |
52 Wk Range | 12.57 - 42.50 |
Market Cap | $1.31B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 67 |
Short Interest | 26.69% |
Days to Cover | 17.93 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Tarsus Pharmaceuticals (NASDAQ:TARS) through any online brokerage.
Other companies in Tarsus Pharmaceuticals’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Phibro Animal Health (NASDAQ:PAHC), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).
Tarsus Pharmaceuticals has a consensus price target of $52.00.
The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $34.51 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Tarsus Pharmaceuticals.
Tarsus Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Tarsus Pharmaceuticals.
Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.